Yale School of Medicine
New Haven, Connecticut, United States
David A. Braun, MD, PhD is a physician-scientist, an Assistant Professor at the Yale School of Medicine, and a member of the Center of Molecular and Cellular Oncology within the Yale Cancer Center. He received his undergraduate degree at Princeton University in Molecular Biology with Certificates in Engineering Biology and Applications of Computing. He then received his PhD in Computational Biology from the Courant Institute of Mathematical Sciences at New York University and his MD from the Icahn School of Medicine at Mount Sinai. During that time, he also served as the national President of the American Physician Scientists Association, and received the AMA Foundation Leadership Award and the Barry Coller Award for Excellence in Clinical Medicine. He completed a residency in Internal Medicine at Brigham and Women’s Hospital and Harvard Medical School, and was selected as a Chief Medical Resident.
He subsequently completed a clinical fellowship in Medical Oncology and post-doctoral fellowship at Dana-Farber Cancer Institute and Harvard Medical School, where he was the Emil Frei Fellow, the John R. Svenson Fellow, and served as an Instructor of Medicine. He was selected to be part of the Department of Defense’s Academy of Kidney Cancer Investigator, the Immuno-Oncology Young Investigator’s Forum and the SITC Sparkathon for Emerging Leaders Igniting Innovation in cancer immunotherapy. In 2019, he was also named a “NextGen Innovator” by HemOnc Today. Through combined experimental and computational approaches, he aims to better understand the key determinants of anti-tumor immunity in order to develop novel therapies for patients with advanced cancer.
Disclosure information not submitted.